ARANESP - 55513-028-01 - (darbepoetin alfa)

Alphabetical Index


Drug Information of ARANESP

Product NDC: 55513-028
Proprietary Name: ARANESP
Non Proprietary Name: darbepoetin alfa
Active Ingredient(s): 200    ug/.4mL & nbsp;   darbepoetin alfa
Administration Route(s): INTRAVENOUS; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of ARANESP

Product NDC: 55513-028
Labeler Name: Amgen Inc
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA103951
Marketing Category: BLA
Start Marketing Date: 20060814

Package Information of ARANESP

Package NDC: 55513-028-01
Package Description: 1 BLISTER PACK in 1 PACKAGE (55513-028-01) > 1 SYRINGE in 1 BLISTER PACK > .4 mL in 1 SYRINGE

NDC Information of ARANESP

NDC Code 55513-028-01
Proprietary Name ARANESP
Package Description 1 BLISTER PACK in 1 PACKAGE (55513-028-01) > 1 SYRINGE in 1 BLISTER PACK > .4 mL in 1 SYRINGE
Product NDC 55513-028
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name darbepoetin alfa
Dosage Form Name INJECTION, SOLUTION
Route Name INTRAVENOUS; SUBCUTANEOUS
Start Marketing Date 20060814
Marketing Category Name BLA
Labeler Name Amgen Inc
Substance Name DARBEPOETIN ALFA
Strength Number 200
Strength Unit ug/.4mL
Pharmaceutical Classes Erythropoiesis-stimulating Agent [EPC],Erythropoietin [Chemical/Ingredient],Increased Erythroid Cell Production [PE]

Complete Information of ARANESP


General Information